John Overdeck’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,790
Closed -$245K 3332
2024
Q2
$245K Sell
23,790
-20,610
-46% -$223K ﹤0.01% 2669
2024
Q1
$480K Sell
44,400
-6,400
-13% -$70.2K ﹤0.01% 2358
2023
Q4
$387K Sell
50,800
-2,362
-4% -$17.1K ﹤0.01% 2585
2023
Q3
$455K Sell
53,162
-8,794
-14% -$88.6K ﹤0.01% 2317
2023
Q2
$683K Buy
61,956
+4,175
+7% +$51K ﹤0.01% 2173
2023
Q1
$764K Sell
57,781
-1,030
-2% -$15.2K ﹤0.01% 2011
2022
Q4
$741K Buy
58,811
+57,654
+4,983% +$2.85M ﹤0.01% 1850
2022
Q3
$112K Sell
1,157
-4,934
-81% -$564K ﹤0.01% 2215
2022
Q2
$563K Buy
+6,091
New +$863K ﹤0.01% 1781

Other funds holding TIL

John Overdeck's TIL Position: Q3 2024 in Review

John Overdeck sold out of Instil Bio (TIL) in Q3 2024, closing a stake of 23,790 shares — an estimated $245K sold.

John Overdeck first reported a position in TIL in Q2 2022 and held it in 9 quarters. The position peaked at $764K in Q1 2023. 49 funds tracked by Wall St. Rank hold TIL as of Q3 2024.

  • John Overdeck reported no remaining Instil Bio position as of Q3 2024 after selling out during the quarter.
  • John Overdeck sold 23,790 Instil Bio shares in Q3 2024, an estimated $245K.
  • John Overdeck first reported a position in Instil Bio in Q2 2022 and held it in 9 quarters.
  • John Overdeck's Instil Bio position peaked at $764K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Instil Bio as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.